Dr Yee Leong Teoh
is a Public Health Physician with extensive expertise in the area of clinical research and public health. He obtained his MBBS in 1994 and MMed (Public Health Medicine) in 2003 from National University of Singapore. As CEO of Singapore Clinical Research Institute, an Academic Research Organisation within the Ministry of Health Holdings, Singapore, he is involved in spearheading the clinical research initiatives in Singapore and building research partnerships with various public and private organizations in the region. He is also an Adjunct Associate Professor with Saw Swee Hock School of Public Health, National University of Singapore.
Prior to his appointment as CEO of SCRI in May 2013, he was Vice-President and General Manager for Emergent Biosolutions Asia Pacific. In that role, he was involved in the development of various vaccines and immunotherapeutic for this Biotech organisation. He was also Director, Clinical Research and Medical Affairs for GlaxoSmithKline Singapore, Malaysia and Brunei from 2000 to 2005 where he conducted one of the largest Phase 3 clinical trials in Singapore involving more than 6,000 subjects for a Rotavirus vaccine.
Dr Teoh’s previous other senior appointments included being Assistant Commissioner of Public Health (Ministry of the Environment), Physician and Head, Jurong Polyclinic (National Healthcare Group Polyclinics) and Infectious Disease Epidemiologist (Communicable Disease Centre, Tan Tock Seng Hospital, Singapore). He has been involved in many epidemiological studies and clinical trials in Singapore both as Principal Investigators and also as Pharmaceutical Sponsors in the last 15 years.